Not applicableUnknownNCT04268836What this trial is testingVision Improvement for Patients With Age-Related Macular DegenerationWho this might be right forAge-related Macular Degeneration Optimal Acuity Corporation 200
Large-scale testing (Phase 3)Study completedNCT01436864What this trial is testingA Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMDWho this might be right forNeovascular Age-related Macular Degeneration Chengdu Kanghong Biotech Co., Ltd. 125
Large-scale testing (Phase 3)Study completedNCT03034772What this trial is testingDorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular DegenerationWho this might be right forNeovascular Age-related Macular DegenerationWet Macular Degeneration Wills Eye 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07557121What this trial is testingSafety and Efficacy of AIV007 Periocular Injection in Patients With Neovascular Age-Related Macular DegenerationWho this might be right forNeovascular (Wet) Age-Related Macular Degeneration AiViva BioPharma, Inc. 35
Not applicableStudy completedNCT05082415What this trial is testingReal-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study)Who this might be right forAge-related Macular Degeneration (AMD) Novartis Pharmaceuticals 9,456
Testing effectiveness (Phase 2)Study completedNCT04626128What this trial is testingSafety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMDWho this might be right forNeovascular Age-related Macular Degeneration Clearside Biomedical, Inc. 27
Large-scale testing (Phase 3)Study completedNCT04964089What this trial is testingEvaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)Who this might be right forWet Age-related Macular Degeneration Kodiak Sciences Inc 557
Not applicableStudy completedNCT05110209What this trial is testingReal-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry)Who this might be right forAge-related Macular Degeneration (AMD) Novartis Pharmaceuticals 331,541
Large-scale testing (Phase 3)Ended earlyNCT04757636What this trial is testingOPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)Who this might be right forNeovascular Age-related Macular Degeneration Opthea Limited 998
Post-approval studies (Phase 4)Study completedNCT02305238What this trial is testingJapanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular DegenerationWho this might be right forWet Macular Degeneration Bayer 288
Post-approval studies (Phase 4)Study completedNCT04679935What this trial is testingEfficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration Novartis Pharmaceuticals 52
Not applicableStudy completedNCT05324150What this trial is testingM Charts Versus Amsler Test in Evaluating Metamorphopsia in nAMDWho this might be right forMacular Degeneration, WetMetamorphopsia Ospedale Santa Croce-Carle Cuneo 57
Testing effectiveness (Phase 2)Study completedNCT01134055What this trial is testingDose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular DegenerationWho this might be right forMacular Degeneration GlaxoSmithKline 510
Large-scale testing (Phase 3)Study completedNCT04857177What this trial is testingEvaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular DegenerationWho this might be right forNeovascular(Wet) Age Related Macular Degeneration Chong Kun Dang Pharmaceutical 312
Not applicableActive Not RecruitingNCT06717139What this trial is testingRecurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMDWho this might be right forRetinal DiseasesMacular DegenerationNeovascular (Wet) Age-Related Macular Degeneration St. Erik Eye Hospital 220
Large-scale testing (Phase 3)Looking for participantsNCT07064759What this trial is testingSingle Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration (nAMD) 4D Molecular Therapeutics 480
Testing effectiveness (Phase 2)Study completedNCT03345082What this trial is testingA Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMDWho this might be right forNeovascular Age-related Macular Degeneration Opthea Limited 366
Large-scale testing (Phase 3)Study completedNCT00891735What this trial is testingRanibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)Who this might be right forAge-related Macular Degeneration Genentech, Inc. 1,097
Very early researchNot Yet RecruitingNCT06888492What this trial is testingTo Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)Who this might be right forWet Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degeneration Guangzhou Jiayin Biotech Ltd 8
Post-approval studies (Phase 4)Study completedNCT02581891What this trial is testingManaging Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the EyeWho this might be right forMacular Degeneration Bayer 287